Editas Medicine
EDIT
$5.07
Share price
0.20%
Change (1 day)
-42.52%
Change (1 year)
Market capitalization of Editas Medicine (EDIT)
Market cap: $0.41 Billion
As of June 2024 Editas Medicine has a market cap of $0.41 Billion. This makes Editas Medicine the world's 6218th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Editas Medicine from 2016 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.41 B | -49.6% |
| 2023 | $0.82 B | 35.65% |
| 2022 | $0.60 B | -66.41% |
| 2021 | $1.81 B | -58.45% |
| 2020 | $4.37 B | 171.53% |
| 2019 | $1.60 B | 45.09% |
| 2018 | $1.10 B | -14.3% |
| 2017 | $1.29 B | 117.56% |
| 2016 | $0.59 B |
End of Day market cap according to different sources
On Jun 17th, 2024 the market cap of Editas Medicine was reported to be:
$0.41 Billion
$0.41 Billion
$0.41 Billion
$0.41 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $13.09 M | -96.86% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.38 B | -8.84% | 🇬🇧 UK |
 Novavax NVAX | $2.06 B | 396.36% | 🇺🇸 USA |
 Novocure
NVCR | $2.08 B | 400.70% | Jersey |